Rosetta Genomics receives NYS DOH clinical laboratory approval
The permission will allow patients and physicians residing in the State of New York to attain access to the company’s miRview mets, miRview squamous, and miRview meso tests.
Biologics contract development and manufacturing organisation (CDMO) AsymBio is set to secure 1.2397bn yuan (approximately $184m) from Asymchem Group, Hillhouse Qirui and other investors to support its long-term growth.
Elder Pharma manufactures a range of pharmaceutical product through research and development and also in the manufacturing and marketing of diverse products through licensing agreements with international pharmaceutical